Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway

Pancreatic cancer is a highly aggressive malignancy, which is intrinsically resistant to current chemotherapies. Herein, we investigate whether bisdemethoxycurcumin (BDMC), a derivative of curcumin, potentiates gemcitabine in human pancreatic cancer cells. The result suggests that BDMC sensitizes ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haopeng, Fan, Shengjun, An, Yu, Wang, Xin, Pan, Yan, Xiaokaiti, Yilixiati, Duan, Jianhui, Li, Xin, Tie, Lu, Ye, Min, Li, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347794/
https://www.ncbi.nlm.nih.gov/pubmed/27845899
http://dx.doi.org/10.18632/oncotarget.13272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347794/
https://www.ncbi.nlm.nih.gov/pubmed/27845899
http://dx.doi.org/10.18632/oncotarget.13272

Ejemplares similares